Evidence map›Paper›PMID 39227813›Full record

ReviewMolecular medicine (Cambridge, Mass.)2024

Insights into RNA N6-methyladenosine and programmed cell death in atherosclerosis.

Haijiao Long, Yulu Yu, Jie Ouyang, Hongwei Lu, Guojun Zhao

Abstract readReview
In one paragraph

Review in Molecular medicine (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. mInternational journal of molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haijiao LongHealth Management Center, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yulu YuAfliated Qingyuan Hospital, Guangzhou Medical University (Qingyuan People's Hospital), Qingyuan, Guangdong, China.
Jie OuyangHealth Management Center, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Hongwei LuHealth Management Center, The Third Xiangya Hospital of Central South University, Changsha, 410013, China. hongweilu@csu.edu.cn.
Guojun ZhaoAfliated Qingyuan Hospital, Guangzhou Medical University (Qingyuan People's Hospital), Qingyuan, Guangdong, China. zhaoguojun@gzhmu.edu.cn.

Funding

the National Natural Science Foundation of China 82270519the Natural Science Foundation of Hunan Province 2023JJ30838
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

AdenosineApoptosisAtherosclerosisAnimalsAutophagyHumansRNAAdenosineN-methyladenosineRNAAtherosclerosisDiagnosisN6-methyladenosineProgrammed cell deathTreatment

Identifiers

PMID39227813
PMCPMC11373444

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.